S&P 500   3,960.03 (-0.97%)
DOW   33,742.83 (-0.60%)
QQQ   282.51 (-1.78%)
AAPL   144.44 (-1.49%)
MSFT   247.01 (-1.27%)
META   116.44 (-4.89%)
GOOGL   97.45 (-2.04%)
AMZN   89.24 (-1.94%)
TSLA   178.97 (-1.91%)
NVDA   160.81 (-3.18%)
NIO   13.13 (+2.58%)
BABA   91.91 (+1.54%)
AMD   71.35 (-3.08%)
T   19.12 (+1.97%)
MU   54.24 (+0.37%)
CGC   3.88 (-10.19%)
F   13.26 (-0.90%)
GE   84.88 (+0.26%)
DIS   93.61 (-2.42%)
AMC   7.08 (-4.97%)
PYPL   72.45 (-1.59%)
PFE   50.07 (-1.30%)
NFLX   307.07 (-1.77%)
S&P 500   3,960.03 (-0.97%)
DOW   33,742.83 (-0.60%)
QQQ   282.51 (-1.78%)
AAPL   144.44 (-1.49%)
MSFT   247.01 (-1.27%)
META   116.44 (-4.89%)
GOOGL   97.45 (-2.04%)
AMZN   89.24 (-1.94%)
TSLA   178.97 (-1.91%)
NVDA   160.81 (-3.18%)
NIO   13.13 (+2.58%)
BABA   91.91 (+1.54%)
AMD   71.35 (-3.08%)
T   19.12 (+1.97%)
MU   54.24 (+0.37%)
CGC   3.88 (-10.19%)
F   13.26 (-0.90%)
GE   84.88 (+0.26%)
DIS   93.61 (-2.42%)
AMC   7.08 (-4.97%)
PYPL   72.45 (-1.59%)
PFE   50.07 (-1.30%)
NFLX   307.07 (-1.77%)
S&P 500   3,960.03 (-0.97%)
DOW   33,742.83 (-0.60%)
QQQ   282.51 (-1.78%)
AAPL   144.44 (-1.49%)
MSFT   247.01 (-1.27%)
META   116.44 (-4.89%)
GOOGL   97.45 (-2.04%)
AMZN   89.24 (-1.94%)
TSLA   178.97 (-1.91%)
NVDA   160.81 (-3.18%)
NIO   13.13 (+2.58%)
BABA   91.91 (+1.54%)
AMD   71.35 (-3.08%)
T   19.12 (+1.97%)
MU   54.24 (+0.37%)
CGC   3.88 (-10.19%)
F   13.26 (-0.90%)
GE   84.88 (+0.26%)
DIS   93.61 (-2.42%)
AMC   7.08 (-4.97%)
PYPL   72.45 (-1.59%)
PFE   50.07 (-1.30%)
NFLX   307.07 (-1.77%)
S&P 500   3,960.03 (-0.97%)
DOW   33,742.83 (-0.60%)
QQQ   282.51 (-1.78%)
AAPL   144.44 (-1.49%)
MSFT   247.01 (-1.27%)
META   116.44 (-4.89%)
GOOGL   97.45 (-2.04%)
AMZN   89.24 (-1.94%)
TSLA   178.97 (-1.91%)
NVDA   160.81 (-3.18%)
NIO   13.13 (+2.58%)
BABA   91.91 (+1.54%)
AMD   71.35 (-3.08%)
T   19.12 (+1.97%)
MU   54.24 (+0.37%)
CGC   3.88 (-10.19%)
F   13.26 (-0.90%)
GE   84.88 (+0.26%)
DIS   93.61 (-2.42%)
AMC   7.08 (-4.97%)
PYPL   72.45 (-1.59%)
PFE   50.07 (-1.30%)
NFLX   307.07 (-1.77%)
NASDAQ:DCGO

DocGo - DCGO Stock Forecast, Price & News

$6.72
-0.12 (-1.75%)
(As of 12/6/2022 11:19 AM ET)
Add
Compare
Today's Range
$6.63
$7.21
50-Day Range
$6.64
$11.10
52-Week Range
$4.96
$11.41
Volume
11,189 shs
Average Volume
897,161 shs
Market Capitalization
$691.02 million
P/E Ratio
15.27
Dividend Yield
N/A
Price Target
$12.25

DocGo MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
79.1% Upside
$12.25 Price Target
Short Interest
Healthy
5.50% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.08mentions of DocGo in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
25.00%
From $0.28 to $0.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Medical Sector

84th out of 1,023 stocks

Local, Suburban Transit & Interurban Highway Passenger Transport Industry

1st out of 1 stocks

DCGO stock logo

About DocGo (NASDAQ:DCGO) Stock

DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Receive DCGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter.

DCGO Stock News Headlines

3 IPO Stocks That You Want to Own - Nasdaq
DocGo Continues Growth Track in UK with Three New Contracts
DocGo Announces Redemption of All Outstanding Warrants
DocGo Announces Strong Second Quarter 2022 Results
See More Headlines
Receive DCGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter.

DCGO Company Calendar

Today
12/06/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/13/2023

Industry, Sector and Symbol

Industry
Local, suburban transit & interurban highway passenger transport
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DCGO
Fax
N/A
Employees
2,924
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.25
High Stock Price Forecast
$14.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+82.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$23.74 million
Pretax Margin
9.94%

Debt

Sales & Book Value

Annual Sales
$318.72 million
Cash Flow
$0.25 per share
Book Value
$2.27 per share

Miscellaneous

Free Float
82,539,000
Market Cap
$691.02 million
Optionable
Not Optionable
Beta
0.65

Key Executives

  • Mr. Stan Vashovsky (Age 49)
    Co-Founder, Chairman & CEO
    Comp: $3.08M
  • Mr. Anthony Capone (Age 34)
    Pres
    Comp: $1.62M
  • Mr. Andre Oberholzer CPA (Age 63)
    Chief Financial Officer
    Comp: $1.75M
  • Mr. Ely D. Tendler (Age 54)
    Gen. Counsel, Sec. & Director
  • Mr. Lee Bienstock (Age 38)
    Chief Operating Officer
  • Mr. Stephen Sugrue (Age 50)
    Chief Compliance Officer
  • Mr. Ben Sherman
    EVP of Corp. Devel.
  • Ms. Rosemarie Milano
    VP of HR
  • Mr. Norman Rosenberg (Age 52)
    Chief Financial Officer of Ambulnz Holdings, LLC
  • Dr. Mark Merlin (Age 54)
    Chief Medical Officer of Ambulnz Holdings, LLC













DCGO Stock - Frequently Asked Questions

Should I buy or sell DocGo stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DCGO shares.
View DCGO analyst ratings
or view top-rated stocks.

What is DocGo's stock price forecast for 2023?

3 brokerages have issued 12 month price targets for DocGo's stock. Their DCGO share price forecasts range from $10.00 to $14.00. On average, they anticipate the company's share price to reach $12.25 in the next twelve months. This suggests a possible upside of 79.1% from the stock's current price.
View analysts price targets for DCGO
or view top-rated stocks among Wall Street analysts.

How have DCGO shares performed in 2022?

DocGo's stock was trading at $9.35 at the beginning of 2022. Since then, DCGO stock has decreased by 26.8% and is now trading at $6.84.
View the best growth stocks for 2022 here
.

Are investors shorting DocGo?

DocGo saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 4,370,000 shares, a decrease of 11.4% from the October 31st total of 4,930,000 shares. Based on an average daily trading volume, of 773,600 shares, the short-interest ratio is presently 5.6 days. Approximately 5.5% of the company's stock are sold short.
View DocGo's Short Interest
.

When is DocGo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 13th 2023.
View our DCGO earnings forecast
.

What guidance has DocGo issued on next quarter's earnings?

DocGo issued an update on its FY 2022 earnings guidance on Monday, November, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $430.00 million-$440.00 million, compared to the consensus revenue estimate of $429.70 million.

What is DocGo's stock symbol?

DocGo trades on the NASDAQ under the ticker symbol "DCGO."

Who are DocGo's major shareholders?

DocGo's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.38%), Vanguard Group Inc. (4.10%), Emerald Advisers LLC (1.85%), State Street Corp (1.80%), Emerald Mutual Fund Advisers Trust (1.52%) and Light Street Capital Management LLC (1.38%).

How do I buy shares of DocGo?

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DocGo's stock price today?

One share of DCGO stock can currently be purchased for approximately $6.84.

How much money does DocGo make?

DocGo (NASDAQ:DCGO) has a market capitalization of $703.36 million and generates $318.72 million in revenue each year. The company earns $23.74 million in net income (profit) each year or $0.44 on an earnings per share basis.

How many employees does DocGo have?

The company employs 2,924 workers across the globe.

How can I contact DocGo?

The official website for the company is www.docgo.com. The company can be reached via phone at 844-443-6246 or via email at ir@docgo.com.

This page (NASDAQ:DCGO) was last updated on 12/6/2022 by MarketBeat.com Staff